Alexion Pharmaceuticals, Inc.

NASDAQ: ALXN
$115.21
+$1.53 (+1.3%)
Closing price June 5, 2020
The August 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Chris Lange
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Chris Lange
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Chris Lange
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most...
Chris Lange
The June 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Chris Lange
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest in most...
Chris Lange
The May 15 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Chris Lange
Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and predictability in the base businesses of two key biotech leaders.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Thursday included AK Steel, Amgen, Booking, Chubb, Chipotle Mexican Grill, Expedia, Gilead Sciences, Goodyear, Philip Morris, Target and...
Jon C. Ogg
The April 30 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Chris Lange
The April 15 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top exchange-traded funds for a breakdown of what they own to show how much they are lagging...
Jon C. Ogg
The March 29 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Chris Lange
The February 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Chris Lange